FDA

Health tech Lizzy Lawrence

STAT Plus: Medical devices with screens aren’t accessible to the blind. Congress has a chance to change that

Health Usha Lee McFarling

FDA urged to move faster to fix pulse oximeters for darker-skinned patients

First Opinion Diana Zuckerman

Medicare has different standards than the FDA. That’s how it should be

The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein

Listen: Vertex’s polarizing data, Aduhelm’s adieu, & an FDA icon

First Opinion G. Luke Hartstein and John Torous

STAT Plus: Where do we go from here on digital therapeutics?

Pharma Theresa Gaffney

STAT Plus: Experts critique flawed system for monitoring drugs’ side effects in wake of asthma drug report

D.C. Diagnosis Sarah Owermohle

The end of an era for the FDA’s longtime drug chief

Associated Press

Philips to stop selling sleep apnea machines in U.S. under tentative agreement with FDA, DOJ

The Readout Damian Garde

STAT Plus: How an immunological Trojan horse could treat disease

Politics Sarah Owermohle

STAT Plus: FDA’s Woodcock reflects on more than 30 years at agency — and hints at what’s next

Politics Sarah Owermohle

STAT Plus: Supreme Court slates abortion pill case for March

The Readout Meghana Keshavan

STAT Plus: 23andMe breach targeted Chinese, Jewish populations

Health tech Lizzy Lawrence

STAT Plus: FDA OKs — but doesn’t require — a non-cancer-causing chemical for sterilizing devices

The Readout Meghana Keshavan

STAT Plus: Investigators fault Lilly plant for manufacturing issues

Opinions+ John Whyte

STAT Plus: Some countries are moving to digital prescription drug information for patients. The U.S. shouldn’t follow suit

First Opinion Sneha Dave, Sydney Reed, and Steven Woloshin

The FDA and FTC need to crack down on TikTok and Instagram influencers pitching prescription drugs

Politics John Wilkerson

STAT Plus: FDA sets aggressive deadline for inspection overhaul

Health tech Lizzy Lawrence

STAT Plus: The FDA’s diagnostics chief, who led through Covid, has retired

Health tech Mario Aguilar

STAT Plus: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed

Biotech Adam Feuerstein

STAT Plus: FDA expands approval of CRISPR-based medicine to treat beta thalassemia

The Readout Meghana Keshavan

STAT Plus: The four biotech stories you need to read this morning

Health tech Lizzy Lawrence

STAT Plus: Many doctors are in the dark about how FDA approves devices and drugs, survey finds

The Readout Meghana Keshavan

STAT Plus: Novartis reportedly decides to pass on Cytokinetics

The Readout Damian Garde, Allison DeAngelis, Adam Feuerstein, and Matthew Herper

STAT Plus: The highs — and lows — of JPM 2024 you should pay attention to

Health Elaine Chen

GLP-1 drugs not linked to suicidal thoughts in FDA’s early review

The Readout Damian Garde, Adam Feuerstein, Matthew Herper, and Allison DeAngelis

STAT Plus: JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far

D.C. Diagnosis Sarah Owermohle

Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one

Special Report Sarah Owermohle

HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy

Exclusive Megan Molteni

STAT Plus: The Afghan father aided U.S. soldiers. Now Texas Medicaid won’t pay for his son’s gene therapy